High exposure to PFAS and indicators of placental function in the Ronneby Mother-Child Cohort

Authors: Nielsen, Christel; Mattsson, Kristina; Hjalm, Sofia; Lindh, Christian; Blomberg, Annelise J

Source journal: Placenta (2026-11-12)

DOI: 10.1016/j.placenta.2026.11.005

Abstract

BACKGROUND: Placental toxicity is a proposed pathway for adverse pregnancy outcomes following exposure to perfluoroalkyl substances (PFAS), but evidence is limited. This study investigates associations between mid-pregnancy PFAS concentrations and placental weight, birth weight, birth weight conditional on placental weight, and cross-sectional measurements of pregnancy-associated plasma protein A (PAPP-A) in Ronneby, Sweden, where drinking water was heavily contaminated by firefighting foam. METHODS: We analyzed 214 full-term pregnancies from the Ronneby Mother-Child Cohort. Serum concentrations of seven PFAS congeners were measured in mid-pregnancy maternal serum. Information on placental and birth weight was obtained from medical delivery records. Associations were assessed using generalized additive mixed models and quantile-based g-computation, adjusting for covariates. Effect modification by infant sex was explored. RESULTS: Median PFOS, PFHxS, and PFOA concentrations were 16.0, 9.8, and 1.8 ng/mL, respectively. No overall associations were found between PFAS exposure and any of the outcomes. Infant sex modified the association with birth weight: higher exposure was associated with lower birth weight in females (-32 g per doubling of PFHxS; 95% CI: -62 to -1), while the results in males were small and inconsistent. Higher exposure was associated with lower PAPP-A in male-bearing pregnancies (-4.2% per doubling of PFHxS; 95% CI: -8.6 to 0.4), but not in female-bearing pregnancies. Mixture analysis also suggested a negative association between maternal PFAS concentrations and birth weight in female infants. CONCLUSIONS: Higher mid-pregnancy maternal PFAS exposure was associated with reduced birth weight in female infants, with little evidence of corresponding changes in placental weight or PAPP-A. Other mechanisms may underlie PFAS-related adverse pregnancy outcomes.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.